Oskar Hansson
61 – 70 of 662
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
evoke and evoke+ : design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer’s disease
- Contribution to journal › Article
-
Mark
Benchmarking Alzheimer’s disease prediction : personalised risk assessment using polygenic risk scores across various methodologies and genome-wide studies
- Contribution to journal › Article
-
Mark
Updated appropriate use criteria for amyloid and tau PET : A report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging Workgroup
- Contribution to journal › Scientific review
-
Mark
Plasma p-tau217 in Alzheimer's disease : Lumipulse and ALZpath SIMOA head-to-head comparison
- Contribution to journal › Article
-
Mark
The impact of disease activity and interferon-α on the nervous system in systemic lupus erythematosus
- Contribution to journal › Article
-
Mark
The Alzheimer's Association Global Biomarker Standardization Consortium (GBSC) plasma phospho-tau Round Robin study
- Contribution to journal › Article
-
Mark
Toward a biological definition of neuronal and glial synucleinopathies
- Contribution to journal › Article
-
Mark
Balance and gait disorders in de novo Parkinson’s disease : support for early rehabilitation
- Contribution to journal › Article
-
Mark
Associations between the EAT-Lancet planetary health diet and incident dementia
- Contribution to journal › Article
- 2024
-
Mark
Validation, Deployment, and Real-World Implementation of a Modular Toolbox for Alzheimer’s Disease Detection and Dementia Risk Reduction : The AD-RIDDLE Project
- Contribution to journal › Article
